Notably, 10,182 cases (35.2%) were recorded as other indications or lacked documented indications
Insulin-like growth factor 1 and its analogs are most bioavailable when injected because they are not reliably absorbed through the digestive system or skin
Applied in the treatment of a number of veterinary diseases, among them respiratory and in some eye diseases
What they're saying: According to the lawsuit, one of the plaintiffs switched from Zepbound to Wegovy in August after exhausting all appeals to Caremark, then "experienced a number of side effects, including the return of his Gastroesophageal Reflux Disease, stomach pain, hunger, and, most notably, weight gain." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the lawsuit states